Purchase Order HT942524P0034
Award Date 2/16/24
Potential Completion Date 9/15/24
Potential Value $250K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27709, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
STTR Phase I
Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Health Agency (DHA) awarded a $250,000 Small Business Technology Transfer (STTR) Phase I contract to Zymeron Corporation, a minority-owned biotechnology company. The contract is for an "Automated Blood-In, miRNAs-Out Assay to Detect Circulating and Exosome miRNAs" to support DHA's biomedical research and development efforts. This STTR award is focused on early-stage research and development of innovative technologies aligned with the DHA's mission to provide healthcare...
- This $3 million firm-fixed-price contract was awarded by the Defense Health Agency (DHA) to Zymeron Corporation, a minority-owned small business, under the DHA's Small Business Innovation Research (SBIR) program. The contract supports the development of a "Rapid Sample Processing Device to Support Battlefield Wound Infection Diagnostics", aligning with the DHA's mission to provide innovative medical technologies for military healthcare. The contract has an ultimate completion date of...
- This contract is a $249,999.09 Small Business Innovation Research (SBIR) Phase I award from the Department of the Army Medical Command to Zymeron Corporation, a minority-owned biotechnology company based in Research Triangle Park, North Carolina. The award supports the research and development of a "Novel Antibiotic Targeting Multidrug-Resistant Pseudomonas Aeruginosa Infections." As a prime contractor, Zymeron has experience providing medical research, engineering services, IT...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Threat Reduction Agency (DTRA), a defense agency, to Zymeron Corporation, a minority-owned small business located in Research Triangle Park, North Carolina. The $149,933.01 firm-fixed-price contract is for research and development under the SBIR program, with a period of performance ending on January 11, 2018. Zymeron Corporation is a biotechnology company that specializes in innovative medical research...
- This is a firm fixed-price purchase order awarded to Zymeron Corporation, a minority-owned small business, under the Department of the Army Medical Command's Small Business Innovation Research (SBIR) program. The $250,000.00 Phase I contract is for the research and development of a "Novel Aerosol Therapy for Immediate and Sustained ARDS Management". Zymeron, a biotechnology company focused on areas like drug delivery systems, will perform this medical research at its facilities in...
- The U.S. government's Medical Command (MEDCOM) awarded a $1,100,000.00 firm-fixed-price Small Business Innovation Research (SBIR) Phase II contract to Zymeron Corporation, a minority-owned small business, for the research and development of "Novel Antibiotics Targeting Multidrug-Resistant Pseudomonas Aeruginosa Infections." The contract, which has a completion date of November 10, 2024, is focused on developing innovative solutions to address the challenge of antibiotic-resistant...
- This is a $2,994,281.25 Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to Paranano Wound Care LLC, a small business, under the SBIR (Small Business Innovation Research) program. The contract is for Phase II of a project titled "The BIOZ Smart Bandage Empowering Priority Response to Pathogen Invasion in Wounds" and has an ultimate completion date of July 11, 2027. The contract is focused on medical research and development related to wound care and pathogen...
- The Zymeron Corporation was awarded a $299,998 firm fixed price Small Business Innovation Research Program Phase I contract from the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract is for the research and development of a rapid point-of-care diagnostic test for histoplasmosis. This award falls under the larger SBIR solicitation issued by NIH and CDC seeking proposals in areas including cancer immunotherapy manufacturing, opioid withdrawal...
- The Defense Health Agency has awarded a $1.3 million Phase II Small Business Innovation Research (SBIR) contract to Ifyber LLC, a small business specializing in biofilm characterization and medical device testing. The definitive contract, with a firm fixed price arrangement, runs through January 2028 and is set aside for total small business participation. Work will be performed in Ithaca, New York, and builds on the company's existing research into antimicrobial and anti-biofilm technologies...
- This federal contract award was made by the Defense Health Agency (DHA) to Erivan Bio, LLC, a for-profit limited liability company, for a Small Business Technology Transfer (STTR) Phase I research project titled "Novel Scalable Loading of Antibiotics in Exosomes for Bacterial Wound Infection Prevention". The contract has a firm fixed price of $249,981.86 and a completion date of September 22, 2024. This STTR Phase I award supports research and development to develop a novel approach...